Anteris Technologies’ Post

Aortic stenosis isn’t just a disease of the valve. In this video, Dr. João Cavalcante and Dr. Christopher Meduri discuss the upstream and downstream impacts on the cardiovascular system and implications for aortic stenosis treatment. At Anteris, we are dedicated to moving the conversation forward in TAVR and taking a whole-heart perspective to assess valve performance and define success in TAVR. #aorticstenosis #interventionalcardiology #TAVI #TAVR #MovingtheConversationForward DurAVR® INVESTIGATIONAL USE ONLY. NOT AVAILABLE FOR COMMERCIAL SALE.  EU: Exclusively for clinical investigations. US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use. 

Assessing the 'myocardium' and 'vasculature' alongside aortic valve performance after TAVR is essential. Also, recent studies emphasize the importance of evaluating mitral valve functionality post-TAVR as well.

Dr. Reza Rahavi

Experimental Medicine , Faculty of Medicine, UBC, Vancouver | Medical Content Writing

2mo

What advancements in non-invasive imaging techniques are helping diagnose and manage aortic stenosis more accurately and proactively? https://lnkd.in/gWpgKCbk

Like
Reply
Detlef Mangels

Market entry strategy; Revenue Growth; Marketing/Communcation; Networking; Business Modell; KPI Development; Coach; Speaker;

2mo

I like you apporasch to put the focus on the heart treatment concept instead the TAVI alone.

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics